• /
  • Brussels, Bruxelles-Capitale, Belgium
  • Permanent, Full time
  • Candriam
  • 2018-09-11

Senior Biotechnology Analyst

As part of the Thematic Global Equity team of 8 professionals, you will assist in the management of the Candriam Biotechnology strategy, a successful and fast growing 1,5 billion USD specialist strategy investing in a global selection of listed biotechnology companies.


  • You analyse the public medical data of investigational drugs, both in the pre-clinical setting as well as in human trials. To this end, you also interact with biotechnology company representatives from the scientific staff up to the CEO level. 
  • You put the clinical data in the context of the targeted disease, implying research on the disease characteristics and characteristics of existing treatments.
  • You establish a commercial sales target for the drug(s) once approved, by analysing the prevalence of the disease, the price of existing treatments and the competitive positioning of the investigational drug. 
  • You built a relationship of trust with external analysts and represent Candriam at broker  and/or medical conferences.
  • You establish a fair value for the companies under your assessment using our well vetted valuation methodology and, over time,  help brainstorming on how to further improve our investment process and valuation work.


  • You hold a degree in biotechnology/life sciences. An additional financial degree a strong plus.
  • Prior experience in a financial and/or research environment (wet or dry lab) a strong plus.
  • You are passionate about equity research and investing.
  • You are a team player; determination and ambition are a given.
  • You have an investigational mind set and leave no stone unturned when analyzing a situation.
  • You are fluent in English, both spoken and written.
Brussels, Bruxelles-Capitale, Belgium Brussels Bruxelles-Capitale BE